Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youths: The Best Evidence Synthesis Is a Strong Call for Further Evidence

Cortese, Samuele and Frazier, Jean A (2022) Editorial: Second-Generation Antipsychotics for Bipolar Depression in Youths: The Best Evidence Synthesis Is a Strong Call for Further Evidence. Journal of the American Academy of Child and Adolescent Psychiatry, 61 (2), 128-130. (doi:10.1016/j.jaac.2021.07.004).

Record type: Editorial

Text

Editorial_NMA_bipolar_depression_submission - Accepted Manuscript

Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (40kB)

More information

Accepted/In Press date: 7 July 2021

e-pub ahead of print date: 14 July 2021

Published date: February 2022

Additional Information: Funding Information: Disclosure: Dr. Cortese has served as deputy editor of Evidence-Based Mental Health, associate editor of Child and Adolescent Mental Health, and on the editorial boards of the Journal of Child Psychology and Psychiatry, the Journal of Child and Adolescent Psychopharmacology, and CNS Drugs. He has received honoraria from the Association for Child and Adolescent Mental Health, the British Association for Psychopharmacology, Healthcare Convention, and the Canadian ADHD Resource Alliance. Dr. Frazier has received grant or research support from the National Institute of Mental Health , the Eunice Kennedy Shriver National Institute of Child Health and Human Development , Fulcrum Therapeutics , and Roche . She has served on the editorial board of the Harvard Review of Psychiatry and as associate editor of the Journal of Child and Adolescent Psychopharmacology. Dr. Del Giovane has reported no biomedical financial interests or potential conflicts of interest.

Learn more about Institute for Life Sciences research